‘Undercover chlamydia’: Inquiries confirm no naughty deeds under the covers

+Practice

In print

SEXUAL HEALTH

‘Undercover chlamydia’: Inquiries confirm no naughty deeds under the covers

2 February 2022

By Massimo Giola

Wednesday 2 February 2022, 12:20 AM

No need to go undercover to expose an extramarital affair, many chlamydia “reinfections” are due to endogenous recolonisation [Image: Devin Kaselnak on Unsplash]

We welcome back infectious disease and sexual health specialist Massimo Giola as a regular contributor in 2022. Starting with chlamydia, each article in this series will cover one topic of interest, present a clinical case and explain the rationale for some of the recommendations in the new Aotearoa New Zealand STI Management Guidelines for use in primary care

Key points, There is growing evidence that sexually transmitted Chlamydia trachomatis establishes a persistent rectal reservoir that is refractory to treatment wi, Pract Green w Pale Yellow

Reproductive Health

Genitourinary

Infectious Disease

Medicines and Therapies

References

Further reading:

Khosropour CM, Dombrowski JC, Vojtech L, et al. Rectal Chlamydia trachomatis infection: A narrative review of the state of the science and research priorities. Sex Transm Dis 2021;48(12):e223–27.
Rank RG, Yeruva L. Hidden in plain sight: chlamydial gastrointestinal infection and its relevance to persistence in human genital infection. Infect Immun 2014;82(4):1362–71.
Kong FY, Tabrizi SN, Fairley CK, et al. The efficacy of azithromycin and doxycycline for the treatment of rectal chlamydia infection: a systematic review and meta-analysis. J Antimicrob Chemother 2015;70(5):1290–97.
Chandra NL, Broad C, Folkard K, et al. Detection of Chlamydia trachomatis in rectal specimens in women and its association with anal intercourse: a systematic review and meta-analysis. Sex Transm Infect 2018;94(5):320–26.

How to Treat

+How to treat

FREE READ

COPD: Prevent, treat and comfort

Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management

Wednesday 26 March 2025, 12:50 AM